These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 26099010
1. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C. Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010 [Abstract] [Full Text] [Related]
2. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De Maglio G, den Bakker MA, Di Francesco L, Kalil RK, Athanasou NA, O'Donnell P, McCarthy EF, Flanagan AM. Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055 [Abstract] [Full Text] [Related]
3. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases. Sangoi AR, Karamchandani J, Lane B, Higgins JP, Rouse RV, Brooks JD, McKenney JK. Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418 [Abstract] [Full Text] [Related]
4. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Sangoi AR, Dulai MS, Beck AH, Brat DJ, Vogel H. Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275 [Abstract] [Full Text] [Related]
5. Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury. Clayton EF, Ziober A, Yao Y, Bing Z. Ann Diagn Pathol; 2013 Apr; 17(2):192-7. PubMed ID: 23218904 [Abstract] [Full Text] [Related]
6. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining. Rekhi B, Banerjee D, Ramadwar M, Bajpai J, Jambhekar NA. Indian J Pathol Microbiol; 2017 Apr; 60(3):350-354. PubMed ID: 28937370 [Abstract] [Full Text] [Related]
7. Chordoma: Immunohistochemical Analysis of Brachury. Sun HI, Guduk M, Gucyetmez B, Yapicier O, Pamir MN. Turk Neurosurg; 2018 Apr; 28(2):174-178. PubMed ID: 28094431 [Abstract] [Full Text] [Related]
8. Patterns of brachyury expression in chordomas. Dridi M, Boutonnat J, Dumollard JM, Peoc'h M, Karpathiou G. Ann Diagn Pathol; 2021 Aug; 53():151760. PubMed ID: 33989961 [Abstract] [Full Text] [Related]
9. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Miettinen M, McCue PA, Sarlomo-Rikala M, Rys J, Czapiewski P, Wazny K, Langfort R, Waloszczyk P, Biernat W, Lasota J, Wang Z. Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643 [Abstract] [Full Text] [Related]
10. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases. Jambhekar NA, Rekhi B, Thorat K, Dikshit R, Agrawal M, Puri A. Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140 [Abstract] [Full Text] [Related]
11. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors. Pinto F, Cárcano FM, da Silva ECA, Vidal DO, Scapulatempo-Neto C, Lopes LF, Reis RM. Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711 [Abstract] [Full Text] [Related]
12. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody. Hamilton DH, Fernando RI, Schlom J, Palena C. Oncotarget; 2015 Mar 10; 6(7):4853-62. PubMed ID: 25605015 [Abstract] [Full Text] [Related]
13. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. Zhang L, Guo S, Schwab JH, Nielsen GP, Choy E, Ye S, Zhang Z, Mankin H, Hornicek FJ, Duan Z. PLoS One; 2013 Mar 10; 8(9):e75851. PubMed ID: 24086644 [Abstract] [Full Text] [Related]
14. SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases. Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J, Lee YS. Am J Surg Pathol; 2014 Mar 10; 38(3):410-20. PubMed ID: 24525512 [Abstract] [Full Text] [Related]
15. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor. Kohashi K, Yamamoto H, Yamada Y, Kinoshita I, Oda Y. Hum Pathol; 2021 Jun 10; 112():1-8. PubMed ID: 33741347 [Abstract] [Full Text] [Related]
16. Primary lung chordoma: a case report. Shigeta N, Isaka T, Ono K, Tanaka M, Yokose T, Adachi H, Usuba W, Ito H. Diagn Pathol; 2024 Jul 03; 19(1):91. PubMed ID: 38961474 [Abstract] [Full Text] [Related]
17. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. J Pathol; 2006 Jun 03; 209(2):157-65. PubMed ID: 16538613 [Abstract] [Full Text] [Related]
18. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma. Otani R, Mukasa A, Shin M, Omata M, Takayanagi S, Tanaka S, Ueki K, Saito N. J Neurosurg; 2018 May 03; 128(5):1428-1437. PubMed ID: 28753115 [Abstract] [Full Text] [Related]
19. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. Hsu W, Mohyeldin A, Shah SR, ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, Wolinsky JP, Gokaslan ZL, Quiñones-Hinojosa A. J Neurosurg; 2011 Oct 03; 115(4):760-9. PubMed ID: 21699479 [Abstract] [Full Text] [Related]